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Abstract
Background: Spinal metastasis is considered to have a worse prognosis in lung cancer than in other cancers, but
recent clinical studies report improved overall survival of lung cancer. We compared the postoperative prognoses of
vertebral metastatic tumors from lung with other types of cancer.
Methods: From 2011 to 2015, 31 Japanese patients (mean age 73 years, range 55–88 years; 19 males, 12 females)
underwent surgery for spinal metastasis at our center. We observed patients retrospectively in March 2016, dividing
them into groups by cancer type: lung (LK group, n = 10); prostate, breast, or thyroid (PB group, n = 12); and other
(OT group, n = 9). We compared survival and revised Tokuhashi score, which provides a basis for choosing a
treatment course. Neurologic status was graded before and after surgery using the Frankel system.
Results: Mean follow-up was 16.5 months (range 1–62 months). Only seven of 31 patients (22.6%) were alive at
final follow-up. Frankel grade significantly improved postoperatively only in the LK (P = 0.01) and PB (P = 0.048)
groups. Revised Tokuhashi score differed across groups (P < 0.0001), and was significantly lower in the LK group
than in the PB group (P = 0.00) and OT group (P = 0.02). Postoperative survival was significantly shorter in the LK
group than in the PB group (P = 0.01) but did not differ between the LK and OT groups.
Conclusions: The revised Tokuhashi score may underestimate the survival of lung cancer patients, who may derive
the same benefit from surgical intervention as those with vertebral metastasis from other cancer types.
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Background
Lung cancer is the third most common cancer, and the
most common cause of cancer death in Japan [1]. However,
overall survival of lung cancer has recently improved [2].
Bone metastases from lung cancer are common, affecting
36% of patients with advanced lung cancer [3]. The spine is
the most common site of metastatic lesions, which can
impair mobility and functional independence [3]. On hist-
ology, adenocarcinoma and squamous cell carcinoma are
associated with higher and lower risks of developing bone
metastases [4]. Surgery is the most effective method of pain
relief and recovery from palsy due to paraparesis from ver-
tebral metastasis, and is therefore the treatment of choice
when survival longer than 3 months is predicted [5, 6]. The
treatment strategy and procedure should be based on life ex-
pectancy [7–9]; the revised Tokuhashi score is generally used
to evaluate the prognosis of patients with a metastatic verte-
bral tumor before considering surgical treatment [10–18].
The revised Tokuhashi score is based on six parameters,
including patient condition, number of bone metastases
outside spine, metastasis to major organs, primary site, and
palsy (Table 1). “Palsy” is evaluated using Frankel scores.
Frankel scores are defined as follows: A, complete neuro-
logical injury; B, preserved sensation only; C, preserved
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motor, nonfunctional; D, preserved motor, functional; E,
normal (no neurological injury). Proper use of the revised
Tokuhashi score to determine whether, on the basis of life
expectancy, a patient is a surgical candidate can help surgical
decision-making in patients with spinal metastases [16–18].
The prognosis of lung cancer metastatic to the spine is
considered worse than that of other cancers with spinal
metastases [7–9, 19]. However, recent clinical studies have
shown improvement in the overall survival of lung cancer
[2]. This progress has been facilitated by the introduc-
tion of new drugs, and by patient selection based on
the recognition that different histological subtypes and
driver mutations determine the biology of these
malignancies and predict drug efficacy [20]. Therefore,
whether the revised Tokuhashi score properly evaluates the
prognosis of lung cancer has been called into question. For
patients with vertebral metastases, we choose surgery when
survival greater than 3 months is expected based on either
the original or an unknown malignancy.
The purpose of this study was to compare the prognoses
of surgically treated patients with a vertebral metastatic
tumor from lung versus other cancers, and to determine
whether the revised Tokuhashi score properly evaluates the
prognosis of lung cancer.
Methods
Thirty-three consecutive Japanese patients underwent sur-
gery for treatment of spinal metastases at Akita Kousei
Medical Center from April 2011 to September 2015.
Thirty-one patients (mean age 73.4 years, range 55–88
years; 19 males, 12 females) were included in the study.
Two patients were removed because of a lack of clinical
data. We observed patients retrospectively in March of
2016. The primary lesions were lung (n = 10), and other
(n = 21). Lung cancers were categorized by histology as
non-small-cell lung cancer in nine patients and small-cell
lung cancer in one patient. Preoperative assessments in-
cluded medical history, history of primary tumors, and
spinal magnetic resonance imaging. Expected survival
>3 months was used as a criterion for choosing surgical
treatment [5, 6]. Patient survival and physical and neuro-
logical status were noted. The prognosis was evaluated
retrospectively using the revised Tokuhashi score. Neuro-
logical status was graded before and after surgery using
the Frankel system [21]. The postoperative Frankel grade
was assigned 1–2 months after surgery, at which time the
neurological status was likely to be maximal.
Cases were divided into three groups: lung cancer (LK
group, n = 10); prostate, breast, or thyroid cancer (PB group,
n = 12); and other (OT group, n = 9), and revised Tokuhashi
score and survival periods were compared. Patients’ profiles
are shown in Table 2. Survival rates were compared using
Kaplan–Meier analysis and the log-rank statistic. All data
are expressed as a mean ± standard deviation. All tests of
significance were two-tailed, and differences with a P value
<0.05 were considered statistically significant. All statistical
analyses were performed with EZR (Saitama Medical
Center, Jichi Medical University, Saitama, Japan), which is a
graphical user interface for R (The R Foundation for
Statistical Computing, Vienna, Austria).
Results
Clinical data for all patients, including primary tumor
type and location of metastases, are presented in Table 2.
All patients had neurological deficits. Mean follow-up
was 16.5 months (range 1–62 months). At final follow-
up, seven of the 31 patients were alive.
Group comparisons of age, sex, and initial stage were
performed with the Kruskal–Wallis test [22], which is a
nonparametric method for testing, and there was no signifi-
cant difference among the groups.
Overall, Frankel classifications improved postoperatively
(P = 0.00). The mean revised Tokuhashi score was 8.0
(range 1–14). Regarding surgical interventions, total en bloc
spondylectomy was performed in three patients, anterior
spinal decompression and instrumentation in one patient,
posterior spinal decompression and instrumentation in 25
patients, and laminectomy alone in two patients.
Table 1 Modified Tokuhashi score
Prognosis parameter Score
General condition
Poor (performance status 10–40%) 0
Moderate (performance status 50–70%) 1
Good (performance status 80–100%) 2









Lung, osteosarcoma, stomach, bladder, esophagus, pancreas 0




Thyroid, breast, prostate, carcinoid tumor 5
Palsy
Complete (Frankel A, B) 0
Incomplete (Frankel C, D) 1
None (Frankel E) 2
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The Frankel classification improved significantly pre-
operatively to postoperatively in the LK (P = 0.01) and
PB (P = 0.047) groups, but not in the OT group.
Mean revised Tokuhashi scores for each group are pre-
sented in Table 2. Group comparisons of the revised
Tokuhashi score were performed with the Kruskal–Wallis
test. The revised Tokuhashi score differed significantly
across groups (Kruskal–Wallis chi-squared = 22.1, degrees
of freedom = 2, P < 0.0001). Pairwise comparisons using
the Mann–Whitney U test revealed the Tokuhashi score
of the LK group to be significantly lower than that of both
the PB group (P = 0.00) and OT group (P = 0.02). There
was no significant difference in the survival period with
initial stages of “localized” or “early locally advanced”
carcinoma compared with “late locally advanced” or “me-
tastasized” carcinoma (Mann–Whitney U test).
Mortality after the operation was compared among
groups by applying Kaplan–Meier analysis and the log-
rank statistic. The postoperative survival period differed
significantly among the three groups (P = 0.00, Fig. 1).
Pairwise comparisons using the log rank test revealed the
survival period of the LK group to be significantly shorter
than that of the PB group (P = 0.01), but there was no
difference between the LK and OT groups (Fig. 1). The
median survival time after the surgical treatment was
7.5 months in the LK group, 44.0 months in the PB group,
and 8.0 months in the OT group.
Discussion
The prognostic factors associated with spinal metastases are
unclear. Surgery can improve mechanical stability, cord
compression, and pain, and may be considered when a
patient has a life expectancy of >3 months [5, 6]. Palliative
surgery for spinal metastasis can improve the quality and
length of life [23]. The revised Tokuhashi score is an import-
ant and effective tool for considering the prognosis of
patients with a metastatic vertebral tumor [10–18]. Spinal
metastases are considered to carry a worse prognosis in
patients with lung cancer compared with other cancers [7–
9, 19]; therefore, conservative treatment is selected for many
lung cancer patients. However, improvements in chemother-
apy, radiotherapy, and hormonal therapies have led to in-
creased survival times for patients with lung cancer [2, 20].
Our results show that the postoperative survival period
after surgical treatment of vertebral metastases was sig-
nificantly shorter in the LK group than in the PB group,
but did not differ between the LK and OT groups, even
though the revised Tokuhashi score of the LK group was
significantly lower than that of the PB and OT groups.
The present study highlights two important clinical is-
sues. First, some cases of vertebral metastasis from lung
cancer can be expected to have a long survival period. Pa-
tients with a revised Tokuhashi score of 0–8 are expected
to survive <3 months. In the revised Tokuhashi scoring
system, lung cancer is assigned 0 points, giving a low score
Fig. 1 Survival curves of patients with spinal metastases from lung (LK) versus prostate, breast, or thyroid primary tumor (PB) versus other cancers (OT).
The postoperative survival period differed significantly among the three groups (P= 0.00). Pairwise comparisons using the log rank test revealed the
survival period of the LK group to be significantly shorter than that of the PB group (P= 0.01), but there was no difference between the LK and OT groups
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to a lung cancer patient with Frankel C palsy. However, a
lack of correlation between the revised Tokuhashi score
and the survival period has been reported for patients with
spinal metastases of lung cancer [24–26]. Ogihara et al.
recommended surgical treatment of spinal metastases
from lung cancer for patients without hypercalcemia or
hypoalbuminemia [24]. Bilsky et al. showed that, when
considering surgical intervention, patient-by-patient
assessment may be more important than the result of a
scoring instrument such as the Tokuhashi score [27].
Second, the present study demonstrates that, when con-
sidering treatment of vertebral metastasis of lung cancer,
surgical treatment may be appropriate even if the revised
Tokuhashi score is <8 points. Chemotherapy, radiotherapy,
and surgery are three treatment options for spinal metasta-
ses; of these, surgery is most effective for early mobilization
and return to functional ambulation, but it is also the most
invasive treatment and risks complications such as infection
and worsening of palsy. However, only one of the 11 lung
cancer patients in the present study had a severe postopera-
tive complication; that patient (patient #7, Table 2) died
from a surgical site infection 1 month after surgery. Despite
the fears surrounding the invasiveness of surgery and its as-
sociated risks, we had a low rate of surgical complication.
Hirabayashi et al. showed that postoperative ambulation
was associated with a longer survival time after surgery for
spinal metastases in patients with lung cancer [23]. Surgical
treatment for a vertebral tumor from lung cancer can
improve the quality of life and survival time [28]. Therefore,
considering the advances made in lung cancer treatment
and the results of the present study, we believe that the
revised Tokuhashi score requires further revision, and that
a primary cancer site score of 0 for lung cancer may no
longer be justified. Because the average score for the pri-
mary cancer site in the OT group was 2.4, we believe that a
score of 2 for lung cancer may be appropriate.
The limitations of the present study were its relatively
small number of patients, the heterogeneity of the OT
group, and the questionable validity of comparing the
LK and OT groups.
Conclusions
The revised Tokuhashi score may underestimate the sur-
vival of lung cancer patients, who could derive the same
benefit from surgical intervention as those with vertebral
metastasis from other types of cancer.
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